High blood pressure, also known as hypertension, is one of the most common health problems in the world. It affects more than ...
High blood pressure, also called hypertension, is one of the most common health problems in the world. It affects more than 1 ...
Woman's World on MSN
Baxdrostat, a new BP drug, could be a game-changer for hypertension
With almost half of American adults living with high blood pressure, it makes sense that you'd want every possible tool in ...
A highly selective aldosterone synthase inhibitor, lorundrostat, showed promise for blood pressure reduction in a double-blind randomized phase IIb trial. Participants with uncontrolled and otherwise ...
In this Q&A, Mineralys CEO Jon Congleton discusses how targeting aldosterone could reshape hypertension treatment. Aldosterone synthase inhibitors (ASIs) are drawing a lot of attention. What first ...
MADRID, Spain—Baxdrostat (AstraZeneca), an investigational aldosterone synthase inhibitor, provides substantial reductions in blood pressure when added to background therapy in patients with ...
There we go. I'll be making forward-looking statements for the course of the day. So as I noted, Mineralys is focused on how do we target aldosterone in cardiorenal metabolic disorders. We do that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results